GWAS links APOE to neuropsychiatric symptoms in mild cognitive impairment and dementia
Vattathil, S. M.; Blostein, F.; Miller-Fleming, T. W.; Davis, L. K.; Alzheimer's Disease Genetics Consortium (ADGC), ; Alzheimer's Disease Neuroimaging Initiative, ; Wingo, T. S.; Wingo, A. P.
Show abstract
INTRODUCTIONNeuropsychiatric symptoms in dementia (NPS) collectively refer to behavioral and psychological symptoms affecting individuals with mild cognitive impairment (MCI) or Alzheimers disease or related dementia (ADRD). NPS are among the most troubling aspects of living with dementia and their treatments have limited efficacy. We aim to investigate genetic variants contributing to NPS to identify new therapeutic targets. METHODSWe performed a genome-wide association study (GWAS) for nine NPS domains measured by the NPI-Q in 12,800 participants of European ancestry with MCI or ADRD recruited by Alzheimers disease research centers across the U.S. RESULTSWe found genome-wide significant signals for agitation, anxiety, apathy, delusions, and hallucinations in the APOE locus that were driven by the APOE {varepsilon}4 allele. We replicated these findings in two independent datasets. Mediation analyses revealed that MCI/ADRD severity only partially mediated the GWAS signals, except for apathy. DISCUSSIONThese findings suggest the APOE {varepsilon}4 allele influences NPS independently of and beyond its effect on ADRD.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- African Ancestry GWAS of Dementia in a Large Military Cohort Identifies Significant Risk Loci 94%
- Genetic architecture of brain age and its casual relations with brain and mental disorders 94%
- Region-based analysis of rare genomic variants in whole-genome sequencing datasets reveal two novel Alzheimer’s disease-associated genes: DTNB and DLG2 94%
Similar papers in this journal
- Cell-type-specific Alzheimer’s disease polygenic risk scores are associated with distinct disease processes in Alzheimer’s disease 96%
- DNA methylation signatures of Alzheimer's disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-types 96%
- A public resource of single cell transcriptomes and multiscale networks from persons with and without Alzheimer's disease 95%
Similar papers in this journal
- Large-Scale Deep Multi-Layer Analysis of Alzheimer's Disease Brain Reveals Strong Proteomic Disease-Related Changes Not Observed at the RNA Level 94%
- Connecting gene regulatory relationships to neurobiological mechanisms of brain disorders 93%
- Molecular characterization of selectively vulnerable neurons in Alzheimer's Disease 93%
Similar papers in this journal
- Synapse protein signatures in cerebrospinal fluid and plasma predict cognitive maintenance versus decline in Alzheimers disease 95%
- Amyloid and Tau PET positive cognitively unimpaired individuals: Destined to decline? 94%
- Clonal hematopoiesis is associated with protection from Alzheimer’s disease 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.